PUBLISHER: The Business Research Company | PRODUCT CODE: 2057514
PUBLISHER: The Business Research Company | PRODUCT CODE: 2057514
Artificial intelligence or machine learning (AI/ML) medical devices refer to medical devices that incorporate artificial intelligence algorithms or machine learning models to perform medical functions such as diagnosis, prediction, monitoring, treatment planning, or therapeutic intervention. These devices may operate as standalone software applications or be embedded within physical medical equipment. They are used by healthcare professionals including physicians, radiologists, cardiologists, pathologists, laboratory technicians and nurses, as well as by patients in home-care settings. AI/ML medical devices are used during various stages of care, including screening, diagnosis, treatment planning, disease monitoring and post-treatment follow-up. They are increasingly deployed in both acute and chronic care management, enabling faster clinical decision-making and improved operational efficiency. Complementary products include traditional medical imaging systems, electronic health records (EHRs), clinical decision support systems, laboratory diagnostic equipment, wearable monitoring devices and telemedicine platforms. Substitute products include conventional non-AI-enabled medical devices and manual diagnostic interpretation performed solely by healthcare professionals without algorithmic assistance.
The global artificial intelligence or machine learning (AI/ML) medical device market was valued at $2,430.7 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 24.00%.
Shift To Home-Based Care
During the historic period, the artificial intelligence (AI) or machine learning (ML) medical device market was significantly driven by the shift to home-based care. As healthcare systems emphasized decentralized treatment models, chronic disease management increasingly moved outside hospital settings and demand for remote monitoring and continuous patient supervision grew, concerns related to hospital capacity constraints, rising healthcare costs and the need for real-time clinical insights intensified, leading to increased adoption of AI/ML-enabled medical devices designed to support remote diagnostics, predictive analytics, automated alerts and personalized care management across home and community-based settings. For example, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, there were approximately 11,500 home health agencies operating in the United States in 2022, of which 83.5% were for-profit organizations. In the same year, about 3.3 million patients received and ended home health care services. Therefore, the artificial intelligence (AI) or machine learning (ML) medical device market was significantly driven by the rising prevalence of the shift to home-based care during the historic period.
Artificial Intelligence & Autonomous Intelligence
Major companies in the artificial intelligence or machine learning (AI/ML) medical device market are increasingly prioritizing artificial intelligence (AI) and machine learning (ML) to enhance real-time diagnostic accuracy, automated clinical decision support and data-driven patient care optimization while reducing reliance on manual interpretation, traditional imaging protocols and isolated clinical assessments across medical devices and healthcare IT ecosystems. These AI/ML-enabled initiatives leverage advanced data integration, deep learning algorithms, predictive modeling and automated analytics to replace conventional rule-based diagnostic systems with self-optimizing digital architectures that continuously enhance detection precision, improve risk stratification and enable automated clinical recommendations while strengthening device reliability, interoperability and predictive outcome modeling across healthcare providers and hospital systems. For example, in April 2024, Prenosis Inc., a U.S.-based artificial intelligence company enabling precision medicine in acute care, announced FDA De Novo marketing authorization for its Sepsis ImmunoScore, an AI/machine learning software as a medical device designed for early diagnosis and risk prediction of sepsis. The system integrates biomarkers and clinical data to generate a risk score and four discrete risk categories, guiding clinicians in the emergency department or hospital to anticipate deterioration, length of stay, in-hospital mortality and escalation of care within 24 hours.
The global artificial intelligence or machine learning (AI/ML) medical device market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 10.17% of the total market in 2024.
Artificial Intelligence Or Machine Learning (AI/ML) Medical Devices Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence or machine learning (AI/ML) medical devices market as it emerges from the COVID-19 shut down.
Where is the largest and fastest-growing market for artificial intelligence or machine learning (AI/ML) medical device ? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The artificial intelligence or machine learning (AI/ML) medical device market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider artificial intelligence or machine learning (AI/ML) medical device; and compares it with other markets.